The Susan G. Komen organization presents awards to four dedicated physician scientists and a pioneering research advocate for their contributions to advancing breast cancer research and transforming patient care. Dr. Olufunmilayo Olopade and Dr. Daniel Hayes are recognized for their work in basic science and clinical research, respecti...
Geoffrey M. Wahl and Norman Wolmark will receive the Brinker Award for their groundbreaking contributions to cancer genetics, research methodology, and transformative approaches to patient care.
A new study published in JAMA Oncology finds that Medicaid expansion is associated with improved survival rates and decreased mortality rates among patients diagnosed with de novo stage 4 breast cancer. The study also reveals a significant decrease in racial disparities, with mortality rates decreasing by 5.5% among minority groups.
A first-of-its-kind tool has been developed to help doctors better diagnose inflammatory breast cancer (IBC), a rare and aggressive type of breast cancer. The tool, which includes a quantitative scoring system, aims to increase diagnostic accuracy and predict outcomes, guiding treatment decisions.
A groundbreaking study led by Dr. Carlos Caldas has identified a way to predict treatment response in breast cancer patients before treatment begins. The research, published in Nature, uses machine learning algorithms to analyze tumor tissue and DNA/RNA profiles, providing a robust test for predicting therapy response.